Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Melanogenic paracrine and autocrine cytokine networks have recently been discovered in vitro between melanocytes and other types of skin cells. Granulocyte colony-stimulating factor receptor (
CSF3R
) controls the survival, proliferation and differentiation of many kinds of cells, including neutrophils. To understand the function of
CSF3R
and recombinant human granulocyte colony-stimulating factor (rhCSF3) on melanocyte proliferation, this study compared the expression of
CSF3R
and the effects of rhCSF3 in primary human melanocytes, neutrophils and HEL 92.1.7 cells. The results show that
CSF3R
is localized in the cytoplasm and on cell membranes of melanocytes and neutrophils. The percentage of
CSF3R
(+) melanocytes was higher than
CSF3R
(+) HEL 92.1.7 cells, but was lower than
CSF3R
(+) neutrophils. Both
CSF3R
mRNA and
CSF3R
protein levels in melanocytes were higher than in HEL 92.1.7 cells, but were lower than in neutrophils. Treatment with rhCSF3 increased the proliferation of human melanocytes, but not their
tyrosinase
activity. Transcripts of
CSF3R
in human melanocytes, M14, A375 melanoma and A431 squamous cell carcinoma cells were also detected. Expression of the
CSF3R
V3 transcript was lower in melanocytes than in M14, A375 melanoma and A431 squamous cell carcinoma cells. In conclusion, rhCSF3 can promote melanocyte proliferation through
CSF3R
without affecting
tyrosinase
activity.
...
PMID:rhCSF3 accelerates the proliferation of human melanocytes in culture through binding CSF3R and the expression of CSF3R transcripts. 2566 88